Navigation Links
Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
Date:7/5/2012

SAN DIEGO, July 5, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the 7th Annual JMP Securities Healthcare Conference on Thursday, July 12 at 10:30 a.m. Eastern Time in New York, NY, and provide a business overview and update.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at www.optimerpharma.com.  Replays of the presentation will be available at the same location for 90 days following the presentation.

About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD) and is commercializing DIFICID in the US and Canada. Optimer also received marketing authorization for fidaxomicin tablets in the European Union where its partner, Astellas Pharma Europe, is commercializing fidaxomicin under the trade name DIFICLIR™. The company is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem, including Asia. Additional information can be found at http://www.optimerpharma.com.

Contacts Optimer Pharmaceuticals, Inc. David Walsey, VP of Investor Relations and Corporate Communications (858) 964-3418

Canale Communications Jason I. Spark, Senior Vice President 619-849-6005 Jason@canalecomm.com

OPTIMER and DIFICID are trademarks of Optimer Pharmaceuticals, Inc. All other trademarks are the property of their respective owners.


'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
3. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... , UAE, May 23, 2016 ... the importance of Precision Medicine and the role ...     The First International Conference of ... under the distinguished patronage and presence of Sheikh Nahyan bin ... conference focused in Precision Medicine, which helps provide personalized medicine ...
(Date:5/23/2016)... , May 23, 2016   Purdue ... entered into an agreement with Egalet Corporation and ... claims. As part of the agreement the companies ... will enable all three companies to develop and ... "This agreement reflects the commitment of ...
(Date:5/20/2016)... , May 20, 2016 The ... investors believe that the industry is not far from ... today ActiveWallSt.com featured the following four equities: Anacor Pharmaceuticals ... ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free trading ...
Breaking Medicine Technology:
(Date:5/24/2016)... Plains, NJ (PRWEB) , ... May 24, 2016 , ... ... high quality, patient-oriented dental care. From the moment a patient arrives at the ... Steven Tuckman will work with each and every patient to create a complete dental ...
(Date:5/24/2016)... ... ... PhysicianOne Urgent Care, advocators in helping their patients lead the healthiest lives possible, updates ... spring. , The official tick season kicks off in May across the states ... themselves to their prey while they feed off their blood. Like other similar biting ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... its highly anticipated, web-based software module. The cutting-edge feature provides end users ... Integration with Izenda’s self-service business intelligence solution and its analytics engine. ...
(Date:5/24/2016)... Brighton, TN (PRWEB) , ... May 24, 2016 ... ... prenatal vitamin alkaline water, a revolutionary new beverage for pregnant women to prevent ... essential prenatal vitamins and alkaline minerals with the look and taste of water. ...
(Date:5/23/2016)... ... May 23, 2016 , ... Edward D. Buckingham, M.D . is excited ... The annual roster is put out by the National Consumer Advisory Board to honor ... care are considered for this award. , The National Consumer Advisory Board (NCAB) is ...
Breaking Medicine News(10 mins):